the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block
Phase 4
Completed
- Conditions
- Injury of Upper Limb
- Interventions
- Registration Number
- NCT02961361
- Lead Sponsor
- The First Hospital of Qinhuangdao
- Brief Summary
Dexmedetomidine is an α-2 adrenoreceptor agonist and has been extensively used through intravenous infusion，in order to improved the quality of block in regional anesthesia. In this prospective, randomized study, the authors focus on the effect of dexmedetomidine mixed with ropivacaine in coracoid approach brachial plexus block.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- American Society of Anesthesiologists (ASA) physical status I or II;
- Aged 18-60 years;
- The elbow, forearm, wrist or hand surgery
Exclusion Criteria
- History of allergy to local anesthetics;
- Coagulation dysfunction, neuromuscular disease or local infection;
- The operation time is longer than the local anesthetics effective time.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group Dexmedetomidine ropivacaine mixed with dexmedetomidine 40 ml 0.375% ropivacaine mixed with dexmedetomidine was injected after Locating brachial plexus. Group Control ropivacaine 40 ml 0.375% ropivacaine was injected after Locating brachial plexus.
- Primary Outcome Measures
Name Time Method duration time once per hour after surgery until 24 hours after surgery effective analgesia time
- Secondary Outcome Measures
Name Time Method Visual analogue scale 2,6,12,24hour after injection onset time 5,10,15,20,25,30 min after injection